Literature DB >> 26070751

Amphetamine-Type Stimulants: The Early History of Their Medical and Non-Medical Uses.

Nicolas Rasmussen1.   

Abstract

Amphetamine was discovered as a drug in the late 1920s, and its pharmacological effects on attention and cognition, emotions, and appetite were explored thoroughly in the 1930s and 1940s. By the late 1940s, it had achieved medical and market success as an antidepressant and was quickly gaining such success as a diet medication. In contrast, both careful testing and extensive military experience had left the impression that the drugs' benefits for attention and cognition were more subjective than real and that any objective benefits were explained mainly by the drug's mood-elevating effects. Because of its unpatentable status, methamphetamine had been introduced for all the same uses by drug firms competing with the holder of the amphetamine patent. The drugs were being widely used nonmedically and their abuse potential was becoming recognized by medicine, eventually leading to their strict control internationally around 1970.
© 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adderall history; Amphetamine abuse; Amphetamine history; Antidepressant history; Methamphetamine history; Military drug use

Mesh:

Substances:

Year:  2015        PMID: 26070751     DOI: 10.1016/bs.irn.2015.02.001

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  7 in total

1.  Discordant reporting of nonmedical amphetamine use among Adderall-using high school seniors in the US.

Authors:  Joseph J Palamar; Austin Le
Journal:  Drug Alcohol Depend       Date:  2017-10-20       Impact factor: 4.492

Review 2.  [Methamphetamine : Epidemiology, clinical importance and sequelae of abuse].

Authors:  N Arnaud; R Thomasius
Journal:  Nervenarzt       Date:  2017-09       Impact factor: 1.214

3.  Amphetamine Use in the Elderly: A Systematic Review of the Literature.

Authors:  Karina Lúcia Moreira Sassi; Natalia Pessoa Rocha; Gabriela Delevati Colpo; Vineeth John; Antonio Lucio Teixeira
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

4.  Rise, and pronounced regional variation, in methylphenidate, amphetamine, and lisdexamfetamine distribution in the United States.

Authors:  Sneha M Vaddadi; Nicholas J Czelatka; Belsy D Gutierrez; Bhumika C Maddineni; Kenneth L McCall; Brian J Piper
Journal:  PeerJ       Date:  2021-12-21       Impact factor: 2.984

Review 5.  Clinical Characteristics and Management of Methamphetamine-Associated Cardiomyopathy: State-of-the-Art Review.

Authors:  Pavan K V Reddy; Tien M H Ng; Esther E Oh; Gassan Moady; Uri Elkayam
Journal:  J Am Heart Assoc       Date:  2020-05-29       Impact factor: 5.501

Review 6.  The Use of Drosophila to Understand Psychostimulant Responses.

Authors:  Travis James Philyaw; Adrian Rothenfluh; Iris Titos
Journal:  Biomedicines       Date:  2022-01-06

Review 7.  Current and Emerging Treatments for Methamphetamine Use Disorder.

Authors:  Anna Moszczynska
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.